Virtual Reality Supported Mindfulness Meditation After Cardiovascular Surgery (VR-MIND-CVS)

April 5, 2026 updated by: Melike Pehlivan, Kutahya Health Sciences University

Effects of Virtual Reality Supported Mindfulness Meditation on Psychophysiological Outcomes In Patients After Cardiovascular Surgery: An Ecological Momentary Assessment Study

The early postoperative period following cardiovascular surgery is often associated with increased anxiety, stress, and physiological instability. Mindfulness-based interventions and virtual reality applications have emerged as potential supportive approaches to improve psychological well-being and promote recovery in clinical settings.

This study aims to examine the short-term effects of virtual reality-supported mindfulness meditation on psychological and physiological outcomes in patients who have completed the intensive care phase after cardiovascular surgery and have been transferred to the ward.

The study was designed as a quasi-experimental trial including 34 patients (intervention group n=17, control group n=17). In addition to standard postoperative care, the intervention group received a 15-minute virtual reality-supported mindfulness meditation session, while the control group received standard care only.

Psychological outcomes include state anxiety, perceived stress, and positive and negative affect. Physiological parameters include heart rate, blood pressure, respiratory rate, oxygen saturation, and body temperature. Data were collected at multiple time points using an ecological momentary assessment approach.

The findings of this study are expected to contribute to the understanding of the feasibility and short-term effects of virtual reality-supported mindfulness interventions in postoperative cardiovascular surgery patients.

Study Overview

Detailed Description

The early postoperative period following cardiovascular surgery is characterized by increased psychological distress and physiological instability. Patients frequently experience elevated levels of anxiety, perceived stress, and fluctuations in vital signs after being transferred from the intensive care unit to the ward. These factors may negatively affect recovery and overall well-being. Therefore, there is a growing interest in non-pharmacological interventions that can support both psychological and physiological stabilization in this critical period.

Mindfulness-based interventions have been widely used to reduce stress, improve emotional regulation, and enhance overall well-being. In recent years, virtual reality (VR) technologies have been introduced as a novel tool to deliver mindfulness practices through immersive and engaging environments. VR-supported mindfulness may provide a practical and effective approach, particularly for postoperative patients with limited mobility.

This study was designed as a quasi-experimental, non-randomized controlled trial to examine the short-term psychophysiological effects of VR-supported mindfulness meditation in patients after cardiovascular surgery. The study included a total of 34 patients who had completed the intensive care phase and were transferred to the ward (intervention group n=17, control group n=17).

In addition to standard postoperative care, the intervention group received a single 15-minute VR-supported mindful body scan meditation session. The control group received standard care only.

Data collection was conducted using an ecological momentary assessment approach at multiple time points. In the intervention group, measurements were performed before the intervention, immediately after the session (15th minute), at the 1st hour, and at the 3rd hour. In the control group, measurements were obtained at baseline, 1st hour, and 3rd hour.

Psychological outcomes included state anxiety, perceived stress, and positive and negative affect. Physiological parameters included heart rate, systolic and diastolic blood pressure, respiratory rate, oxygen saturation, and body temperature.

The aim of this study is to evaluate the feasibility and short-term effects of VR-supported mindfulness meditation on psychological and physiological outcomes in patients during the early postoperative period following cardiovascular surgery.

Study Type

Interventional

Enrollment (Actual)

34

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients aged 18 to 65 years
  • Patients who underwent coronary artery bypass grafting or heart valve repair surgery
  • Patients monitored in the postoperative period in the clinical ward following the intensive care unit stay
  • Hemodynamically stable patients within the first 12 to 48 hours after surgery, defined as heart rate 60-100 beats/min, blood pressure 90/60-140/90 mmHg, oxygen saturation ≥92%, and respiratory rate 12-20 breaths/min
  • Patients who were conscious, able to communicate verbally, and able to understand and follow instructions
  • Patients without visual or hearing impairment and physically able to use the virtual reality device
  • Patients without a history of psychiatric diagnosis or treatment, based on self-report
  • Patients who voluntarily agreed to participate in the study

Exclusion Criteria:

  • Patients who underwent major vascular surgery such as aortic aneurysm repair, aortic dissection repair, carotid endarterectomy, or thoracoabdominal aortic aneurysm repair
  • Patients who developed serious postoperative complications requiring emergency intervention within the first 12 to 48 hours after surgery, such as acute renal failure, pulmonary embolism, or severe bleeding
  • Patients using continuously high-dose beta-blockers or antiarrhythmic drugs due to uncontrolled hypertension or heart failure
  • Patients with prior experience in mindfulness meditation
  • Patients dependent on mechanical cardiac support devices or requiring continuous mechanical support such as an intra-aortic balloon pump
  • Patients diagnosed with delirium or severe cognitive impairment
  • Patients under isolation precautions for infection control

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Virtual Reality Mindfulness Group
Participants received a 15-minute virtual reality-supported mindfulness meditation session in addition to standard postoperative care.
A 15-minute guided mindfulness body scan meditation delivered through an immersive virtual reality environment in addition to standard postoperative care. The intervention is designed to support psychological relaxation and physiological stabilization in patients following cardiovascular surgery.
Other Names:
  • Virtual Reality Mindfulness
No Intervention: Control Group
Participants received standard postoperative care without any additional intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
State Anxiety
Time Frame: Baseline, immediately after intervention, 1 hour, and 3 hours
State anxiety measured using the State-Trait Anxiety Inventory (STAI-State)
Baseline, immediately after intervention, 1 hour, and 3 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perceived Stress
Time Frame: Baseline, 1 hour, and 3 hours
Measured using the Perceived Stress Scale (PSS-4, short form)
Baseline, 1 hour, and 3 hours
Positive and Negative Affect
Time Frame: Baseline, immediately after intervention, 1 hour, and 3 hours
Measured using the Positive and Negative Affect Schedule (PANAS)
Baseline, immediately after intervention, 1 hour, and 3 hours
Heart Rate
Time Frame: Baseline, immediately after intervention, 1 hour, and 3 hours
Measured in beats per minute using a pulse oximeter
Baseline, immediately after intervention, 1 hour, and 3 hours
Systolic and Diastolic Blood Pressure
Time Frame: Baseline, immediately after intervention, 1 hour, and 3 hours
Measured in mmHg using a digital blood pressure monitor
Baseline, immediately after intervention, 1 hour, and 3 hours
Oxygen Saturation (SpO₂)
Time Frame: Baseline, immediately after intervention, 1 hour, and 3 hours
Measured as percentage (%) using a pulse oximeter
Baseline, immediately after intervention, 1 hour, and 3 hours
Respiratory Rate
Time Frame: Baseline, immediately after intervention, 1 hour, and 3 hours
Measured as breaths per minute by manual counting
Baseline, immediately after intervention, 1 hour, and 3 hours
Body Temperature
Time Frame: Baseline, immediately after intervention, 1 hour, and 3 hours
Measured in °C using a non-contact thermometer
Baseline, immediately after intervention, 1 hour, and 3 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Melike Pehlivan, PhD, Kutahya Health Science University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 30, 2025

Primary Completion (Actual)

December 30, 2025

Study Completion (Actual)

February 2, 2026

Study Registration Dates

First Submitted

April 5, 2026

First Submitted That Met QC Criteria

April 5, 2026

First Posted (Actual)

April 13, 2026

Study Record Updates

Last Update Posted (Actual)

April 13, 2026

Last Update Submitted That Met QC Criteria

April 5, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 324S805 (Other Grant/Funding Number: TUBITAK)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared due to privacy and confidentiality considerations.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress

Clinical Trials on Virtual Reality-Supported Mindfulness Meditation

Subscribe